MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has...

Inspire Medical Systems (NYSE:INSP Get Rating) had its target price boosted by Lake Street Capital from $250.00 to $305.00 in a research note issued to investors on Wednesday, The Fly reports. Several other research firms have also recently issued reports on INSP. KeyCorp increased their ...

Inspire Medical Systems (NYSE:INSP Get Rating) had its price objective upped by Lake Street Capital from $250.00 to $305.00 in a research note issued to investors on Wednesday, The Fly reports. A number of other equities research analysts also recently weighed in on the stock. The Goldman ...

Glancy Prongay & Murray LLP (GPM) announces its investigation of Inspire Medical Systems, Inc. (NYSE: INSP) concerning the Company and its directors and officers possible violations of state laws. If you own Inspire Medical Systems stock, would like to learn more about these claims, or have...

Inspire Medical Systems, Inc. (NYSE:INSP Get Rating) CTO John Rondoni sold 1,170 shares of the companys stock in a transaction dated Tuesday, January 3rd. The stock was sold at an average price of $256.00, for a total transaction of $299,520.00. Following the completion of the sale, the chief ...